Keywords: month, delay, approval, ligand/gsk, promacta, food, drug

3 month delay for approval of Ligand/GSK's Promacta

Article | 14 July 2008

Print This

The US Food and Drug Administration has extended the priority review period for UK drug major GlaxoSmithKline and the USA-based ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in